ABC | Volume 114, Nº2, February 2020

Update Update of the Brazilian Guideline on Nuclear Cardiology – 2020 Arq Bras Cardiol. 2020; 114(2):325-429 therapy evaluated by 123I-MIBGmyocardial scintigraphy. J Nucl Cardiol. 2007;14(6):852-9. 343. Ambardekar AV, Buttrick PM. Reverse remodeling with left ventricular assist devices: a review of clinical, cellular, and mechanistic effects. Circ Heart Fail. 2011;4(2):224–33. 344. Drakos SG, Athanasoulis T, Malliaras KG, Terrovitis JV, Diakos N, Koudoumas G, et al. Myocardial sympathetic innervation and long- term left ventricular mechanical unloading. J Am Coll Cardiol Img. 2010;3(1):64–70. 345. Buendia-Fuentes F, Almenar L, Ruiz C, Vercher JL, Sánchez-Lázaro I, Martínez-Dolz L, et al. Sympathetic reinnervation 1 year after heart transplantation, assessed using iodine-123 metaiodobenzylguanidine. Transplant Proc. 2011;43(6):2247-8. 346. Brandão SC, Giorgi MC, Nishioka SA, Meneghetti JC. Papel da medicina nuclear na terapia de ressincronização cardíaca. Rev bras ecocardiogr imagem cardiovasc. 2011;24(4):62-72. 347. Arora R, Ferrick KJ, Nakata T, Kaplan RC, RozengartenM, Latif F, et al. I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator. J Nucl Cardiol. 2003;10(2):121-31. 348. Verschure DO, de Groot JR, Mirzaei S, Gheysens O, Nakajima K, van Eck- Smit BLF, at al. Cardiac 123I-mIBG scintigraphy is associatedwith freedom of appropriate ICD therapy in stable chronic heart failure patients. Int J Cardiol. 2017 Dec;248:403-8. 349. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med. 2001;42(12):1757-67. 350. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45(7):1104-8. 351. Zipes DP. Heart-brain interactions in cardiac arrhythmias: Role of the autonomic nervous system. Clev Clin J Med. 2008;75(Suppl 2):S94-6. 352. Boogers MJ, Borleffs CJ, Henneman MM, van Bommel RJ, van Ramshorst J, Boersma E, et al. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients. J Am Coll Cardiol. 2010; 55:2769-77. 353. Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, andQT dispersion. J AmColl Cardiol. 2009;53(5):426-35. 354. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al; ADMIRE-HF Investigators. Myocardial iodine-123 meta- iodobenzylguanidine imaging and cardiac events in heart failure: Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation inHeartFailure)study.JAmCollCardiol.2010;55(20):2212-21. 355. Kuramoto Y, Yamada T, Tamaki S, Okuyama Y, Morita T, Furukawa Y, et al. Usefulness of cardiac iodine-123 meta-iodobenzylguanidine imaging to improve prognostic power of Seattle heart failure model in patients with chronic heart failure. Am J Cardiol. 2011;107(8):1185-90. 356. Silva MI, Ferreira MJ, Moreira AP. Utilização da cintilografia com iodo- 123-metaiodobenzilguanidina na estratificação do risco de morte súbita an insuficiência cardíaca. Rev Port Cardiol. 2013;32(6):509-16. 357. Bax JJ, Kraft O, Buxton AE, Fjeld JG, Parízek P, Agostini D, et al. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging. 2008;1(2):131-40. 358. Fallavollita JA, Heavey BM, Luisi AJ Jr, Michalek SM, Baldwa S, Mashtare TL Jr, et al. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63(2):141-9. 359. Rassi A Jr, Rassi SG, Rassi A. Sudden death in Chagas' disease. Arq Bras Cardiol. 2001;76(1):75-96. 360. Rassi A Jr, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375(9723):1388-402. 361. Gadioli LP, Miranda CH, Pintya AO, de Figueiredo AB, Schmidt A, Maciel BC, et al. The severity of ventricular arrhythmia correlates with the extent of myocardial sympathetic denervation, but not with myocardial fibrosis extent in chronic Chagas cardiomyopathy: Chagas disease, denervation and arrhythmia. J Nucl Cardiol. 2018;25(1):75-83. 362. Zipes DP. Influence of myocardial ischemia and infarction on autonomic innervation of heart. Circulation. 1990;82(4):1095–105. 363. Mitrani RD, Klein LS, Miles WM, Hackett FK, Burt RW, Wellman HN, et al. Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol. 1993;22(5):1344-53. 364. Wichter T, Matheja P, Eckardt L, Kies P, Schäfers K, Schulze-Bahr E, et al. Cardiac autonomic dysfunction in Brugada syndrome. Circulation. 2002;12;105(6):702-6. 365. Taki J, Nakajima K, Bunko H, Simizu M, Muramori A, Hisada K. Whole- body distribution of iodine 123metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart. Eur J Nucl Med. 1990;17(5):264-8. 366. Verschure DO, van Eck-Smit BL, Somsen GA, Verberne HJ. Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy. Clin Transl Imaging. 2015;3(5):379-85. 367. Takahashi N, Ishida Y, Maeno M, Hirose Y, Kawano S, Fukuoka S, et al. Noninvasive identification of left ventricular involvements in arrhythmogenic right ventricular dysplasia: comparison of 123I-MIBG, 201TlCl,magneticresonance imagingandultrafastcomputedtomography. Ann Nucl Med. 1997;11(3):233-41. 368. Simoni LJ, Brandão SC. New Imaging Methods for Detection of Drug- Induced Cardiotoxicity in Cancer Patients. Curr Cardiovasc Imaging Rep. 2017;10(6):18. 369. Guimarães SL, Brandão SC, Andrade LR, Maia RJ, Markman Filho B. Cardiac sympathetic hyperactivity after chemotherapy: early sign of cardiotoxicity?. Arq Bras Cardiol. 2015;105(3):228-34. 370. Bulten BF, Verberne HJ, Bellersen L, Oyen WJ, Sabaté-Llobera A, Mavinkurve-Groothuis AM, et al. Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients. Cancer Chemother Pharmacol. 2015;76(5):957–67. 371. CarrióI,CowieMR,Yamazaki J,UdelsonJ,CamiciPG.Cardiacsympathetic imaging withmIBG in heart failure. J AmColl Cardiol Cardiovasc Imaging. 2010;3(1):92-100. 372. Stevens MJ, Raffel DM, Allman KC, Dayanikli F, Ficaro E, Sandford T, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation. 1998;98(10):961-8. 373. Fadi G. Hage, Ami E. Iskandrian. Cardiac Autonomic Denervation in Diabetes Mellitus. Circ Cardiovasc Imaging. 2011 Mar;4:79-81. 374. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M. Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med. 2001;345(10):731-8. 375. Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, et al. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevationmyocardial infarction. Ann InternMed. 2004;141(11):858-65. 376. Sharkey SW, Lesser JR, Zenovich AG, Maron MS, Lindberg J, Longe TF, et al. Acute and reversible cardiomyopathy provoked by stress in women from the United States. Circulation 2005;111(4):472–9. 423